Safety and Efficacy of a Single 48 mm Everolimus-Eluting Stent in Percutaneous Coronary Intervention for Diffuse Coronary Lesions: A propensity score analysis

Safety and Efficacy of a Single 48 mm Everolimus-Eluting Stent in Percutaneous Coronary Intervention for Diffuse Coronary Lesions: A propensity score analysis - Safety and Efficacy of a Single 48 mm Everolimus-Eluting Stent in Percutaneous Coronary Intervention for Diffuse Coronary Lesions: A propensity score analysis

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000047934

Enrollment

Registered

2022-06-03

Start date

2018-06-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Coronary Artery Disease

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Between June 2018 and September 2020, consecutive patients underwent PCI with a single 48mm everolimus-eluting stent or overlapping stents

Exclusion criteria

Exclusion criteria: Multiple stents without overlap

Design outcomes

Primary

Measure	Time frame
adverse events after 2 years (cardiac death, non-fatal myocardial infarction, target lesion revascularization and in-stent restenosis)	—

Secondary

Measure	Time frame
contrast volume, duration of procedure radiation dose	—

Countries

Japan

Contacts

Public ContactDaisuke Sunohara

Shinshu University Hospital Department of Cardiovascular Medicine

sunoharadaisuke@shinshu-u.ac.jp0263-37-3486

Outcome results